Current and Emerging Options for the Management of Inherited von Willebrand Disease

por Heijdra, Jessica M., Cnossen, Marjon H., Leebeek, Frank W. G.
Publicado 2017

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia

por van Moort, Iris, Bukkems, Laura H, Nieuwenhuizen, Laurens, Cnossen, Marjon H
Publicado 2021

Patient-relevant health outcomes for von Willebrand disease, platelet function disorders, and rare bleeding disorders: a Delphi study

por van Hoorn, Evelien S., Lingsma, Hester F., Cnossen, Marjon H., Gouw, Samantha C.
Publicado 2023

In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates

por Preijers, Tim, Bukkems, Laura, van Spengler, Max, Leebeek, Frank, Cnossen, Marjon, Mathôt, Ron
Publicado 2021

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis

por Boeddha, Navin P., Driessen, Gertjan J., Cnossen, Marjon H., Hazelzet, Jan A., Emonts, Marieke
Publicado 2016

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis

por Bukkems, Laura H., Jönsson, Siv, Cnossen, Marjon H., Karlsson, Mats O., Mathôt, Ron A. A.
Publicado 2023

Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation

por Bukkems, Laura H., Goedhart, Tine M.H.J., Zwaan, C. Michel, Cnossen, Marjon H., Mathôt, Ron A.A.
Publicado 2023

A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol

por Madderom, Marlous J., Heijdra, Jessica, Utens, Elisabeth M. W. J., Polinder, Suzanne, Rijneveld, Anita W., Cnossen, Marjon H.
Publicado 2016

Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice

por Goedhart, Tine M. H. J., Bukkems, Laura H., Zwaan, C. Michel, Mathôt, Ron A. A., Cnossen, Marjon H.
Publicado 2021

Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A

por Bukkems, Laura H., Versloot, Olav, Cnossen, Marjon H., Jönsson, Siv, Karlsson, Mats O., Mathôt, Ron A.A., Fischer, Kathelijn
Publicado 2022

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding

por Atiq, Ferdows, Wuijster, Esmee, de Maat, Moniek P.M., Kruip, Marieke J.H.A., Cnossen, Marjon H., Leebeek, Frank W.G.
Publicado 2021

Performance of factor IX extended half‐life product measurements in external quality control assessment programs

por Nederlof, Angelique, Kitchen, Steve, Meijer, Piet, Cnossen, Marjon, Ali Pour, Nae, Kershaw, Geoffrey, Jennings, Ian, Walker, Isobel, de Maat, Moniek P. M.
Publicado 2020

Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views

por Houwing, Maite E., Buddenbaum, Marit, Verheul, Thijs C. J., de Pagter, Anne P. J., Philipsen, Jacobus N. J., Hazelzet, Jan A., Cnossen, Marjon H.
Publicado 2021

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing o...

por Donners, Anouk, van der Zwet, Konrad, Egberts, Antoine C G, Fijnvandraat, Karin, Mathôt, Ron, Kruis, Ilmar, Cnossen, Marjon H, Schutgens, Roger, Urbanus, Rolf T, Fischer, Kathelijn
Publicado 2023

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

por Preijers, Tim, Schütte, Lisette M., Kruip, Marieke J. H. A., Cnossen, Marjon H., Leebeek, Frank W. G., van Hest, Reinier M., Mathôt, Ron A. A.
Publicado 2020

Desmopressin testing in von Willebrand disease: Lowering the burden

por Heijdra, Jessica M., Atiq, Ferdows, Al Arashi, Wala, Kieboom, Quincy, Wuijster, Esmee, Meijer, Karina, Kruip, Marieke J. H. A., Leebeek, Frank W. G., Cnossen, Marjon H.
Publicado 2022

PB2518: OPTIMIZING THE DETECTION OF 2,3- DIPHOSPHOGLYCERATE IN DRIED BLOOD SPOTS OF PATIENTS WITH SICKLE CELL DISEASE: UNTARGETED METABOLOMICS WITHIN THE GENOMED4ALL PROJECT

por van der Veen, Sigrid, van Dijk, Myrthe, Biemond, Bart, Cnossen, Marjon, Colombatti, Raffaella, Jans, Judith, Mañú Pereira, Maria Del Mar, Verhoeven, Nanda, Van Wijk, Richard, van Beers, Eduard
Publicado 2023

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

por van Moort, Iris, Meijer, Piet, Priem‐Visser, Debby, van Gammeren, Adriaan J., Péquériaux, Nathalie C. V., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M.
Publicado 2018

Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study

por van Velzen, Alice S., Eckhardt, Corien L., Peters, Marjolein, Oldenburg, Johannes, Cnossen, Marjon, Liesner, Ri, Morfini, Massimo, Castaman, Giancarlo, McRae, Simon, van der Bom, Johanna G., Fijnvandraat, Karin
Publicado 2020

The one‐stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non‐severe haemophilia A: Superiority or non‐inferiority?

por Schütte, Lisette M., Hodes, Luca S., van Moort, Iris, Stoof, Sara C. M., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M., Kruip, Marieke J. H. A.
Publicado 2020